au.\*:("RAYON, Chelo")
Results 1 to 10 of 10
Selection :
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyCERVERA, José; MONTESINOS, Pau; MILONE, Gustavo et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 424-431, issn 0390-6078, 8 p.Article
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcomeSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2010, Vol 115, Num 25, pp 5137-5146, issn 0006-4971, 10 p.Article
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article
Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based ChemotherapyMONTESINOS, Pau; GONZALEZ, José D; DEBEN, Guillermo et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3872-3879, issn 0732-183X, 8 p.Article
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxisMONTESINOS, Pau; DIAZ-MEDIAVILLA, Joaquin; GONZALEZ, José et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1242-1249, issn 0390-6078, 8 p.Article
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy : characteristics, outcome, and prognostic factorsMONTESINOS, Pau; BERGUA, Juan M; RIVAS, Concha et al.Blood. 2009, Vol 113, Num 4, pp 775-783, issn 0006-4971, 9 p.Article
All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemiaSANZ, Miguel A; VELLENGA, Edo; DE LA SERNA, Javier et al.Blood. 2004, Vol 104, Num 12, pp 3490-3493, issn 0006-4971, 4 p.Article
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupTALLMAN, Martin S; KIM, Haesook T; GONZALEZ, Marcos et al.Blood. 2010, Vol 116, Num 25, pp 5650-5659, issn 0006-4971, 10 p.Article
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicinDE LA SERNA, Javier; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 111, Num 7, pp 3395-3402, issn 0006-4971, 8 p.Article
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupSANZ, Miguel A; MARTIN, Guillermo; DE LA SERNA, Javier et al.Blood. 2004, Vol 103, Num 4, pp 1237-1243, issn 0006-4971, 7 p.Article